Skogestad J, Albert I, Hougen K, Lothe GB, Lunde M, Søvik Eken O, Veras I, Thi-Huynh NT, Børstad M, Marshall S, Shen X, Louch WE, Louise Robinson E, Cleveland JC, Ambardekar AV, Schwisow JA, Jonas E, Calejo AIC, Morth JP, Taskén K, Melleby AO, Lunde PK, Sjaastad I, Carlson CR, Aronsen JM(2023) Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure Circulation(in press) DOI 10.1161/CIRCULATIONAHA.121.054168, PubMed 36876489
Giliberto M, Santana LM, Holien T, Misund K, Nakken S, Vodak D, Hovig E, Meza-Zepeda LA, Coward E, Waage A, Taskén K, Skånland SS(2022) Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines Front Oncol, 12, 1040730 DOI 10.3389/fonc.2022.1040730, PubMed 36523963
Wei Q, Taskén K(2022) Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development Biochem J, 479(20), 2219-2260 DOI 10.1042/BCJ20210233, PubMed 36305711